Evidence map›Paper›PMID 26774947›Full record

ArticleDrug and alcohol dependence2016

Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals.

Raquel B De Boni, Lu Zheng, Susan L Rosenkranz, Xin Sun, Jeffrey Lavenberg, Sandra W Cardoso, Beatriz Grinsztejn, Alberto La Rosa, Samuel Pierre, Patrice Severe and 3 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Drug and alcohol dependence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Predictors of Daily Adherence to Naltrexone for Alcohol Use Disorder Treatment During a Mobile Health Intervention.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2018
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Raquel B De BoniCenter for Biostatistics in AIDS Research (CBAR), Harvard School of Public Health, Boston, MA, USA; Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil. Electronic address: raqueldeboni@gmail.com.
Lu ZhengCenter for Biostatistics in AIDS Research (CBAR), Harvard School of Public Health, Boston, MA, USA.
Susan L RosenkranzCenter for Biostatistics in AIDS Research (CBAR), Harvard School of Public Health, Boston, MA, USA.
Xin SunCenter for Biostatistics in AIDS Research (CBAR), Harvard School of Public Health, Boston, MA, USA.
Jeffrey LavenbergCenter for Biostatistics in AIDS Research (CBAR), Harvard School of Public Health, Boston, MA, USA.
Sandra W CardosoInstituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil.
Beatriz GrinsztejnInstituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil.
Alberto La RosaAsociacion Civil Impacta Salud y Educacion, Lima, Peru.
Samuel PierreInstitut National de Laboratoire et de Recherches, Centres Gheskio, Port au Prince, Haiti.
Patrice SevereInstitut National de Laboratoire et de Recherches, Centres Gheskio, Port au Prince, Haiti.
Susan E CohnNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Ann C CollierHarborview Medical Center, University of Washington, Seattle, WA, USA.
Robert GrossDepartment of Medicine (Infectious Diseases) and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Cancer Research And Biostatistics · USGheskio Centers · HTInstituto Evandro Chagas · BRAsociación Civil Impacta Salud y Educación · PENorthwestern University · USUniversity of Pennsylvania · USUniversity of Washington · US

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)UM1AI068634 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Marlene Ann Cooper, Michael David Hughes · 2011 to 2026
$246.6M
AIDS Clinical Trials Group NetworkU01AI068636 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI KURITZKES, DANIEL R. · 2006 to 2010
$147.1M
Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID S METZGER · 1999 to 2026
$78.6M
UZ-UCSF CTUUM1AI069436 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ZVAVAHERA MIKE CHIRENJE, LYNDA STRANIX-CHIBANDA · 2012 to 2026
$75.9M
THE IMPACTA PERU CLINICAL TRIALS UNITUM1AI069438 · NIAID · ASOCIACION CIVIL IMPACTA SALUD Y EDUCACN · PI Alberto La Rosa, Jorge Luis Sanchez · 2012 to 2026
$43.2M
University of Pennsylvania HIV Clinical Trials UnitUM1AI069534 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Ian Frank, PABLO TEBAS · 2012 to 2026
$33.0M
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplicationUM1AI069463 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI REES, HELEN, SANNE, IAN MATTHIAS · 2012 to 2025
$31.8M
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)UM1AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI BEATRIZ GRINSZTEJN · 2012 to 2026
$26.3M
Northwestern University Clinical Trial UnitUM1AI069471 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Chad J Achenbach · 2012 to 2026
$24.6M
Seattle Vaccine Trials UnitUM1AI069481 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Rachel Ann Bender Ignacio, Margaret Juliana McElrath · 2012 to 2026
$24.4M
Units for HIV/AIDS Clinical Trials NetworksU01AI069463 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI SANNE, IAN MATTHIAS · 2007 to 2011
$24.2M
NIAID NIH HHS 1U01AI069471NIAID NIH HHS 2UM1AI069438-08NIAID NIH HHS AI069438NIAID NIH HHS AI069463NIAID NIH HHS AI069476NIAID NIH HHS P30 AI045008NIAID NIH HHS U01 AI068636NIAID NIH HHS U01 AI069438NIAID NIH HHS U01 AI069463NIAID NIH HHS U01 AI069471NIAID NIH HHS U01 AI069476NIAID NIH HHS UM1 AI068634NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI069434NIAID NIH HHS UM 1AI069436NIAID NIH HHS UM1 AI069438NIAID NIH HHS UM1 AI069463NIAID NIH HHS UM1 AI069471NIAID NIH HHS UM1 AI069476NIAID NIH HHS UM1 AI069481NIAID NIH HHS UM1 AI069534NIMH NIH HHS P30 MH097488PHS HHS 7UMIA1069455PHS HHS U01- A1069501
6 · The paper itself

Abstract

backgroundUnderstanding patterns of antiretroviral adherence and its predictors is important for designing tailored interventions. Alcohol use is associated with non-adherence. This study aimed to evaluate: (1) if there was a difference in weekday compared with weekend adherence in HIV-infected individuals from low and middle income countries (LMIC), and (2) whether binge drinking was associated with this difference.

methodsData from a randomized trial conducted at 9 sites in 8 LMIC were analyzed. Microelectronic monitors were used to measure adherence. Differences between weekday and weekend adherence in each quarter (successive 12-week periods) were compared using Wilcoxon signed rank tests and predictors of adherence, including baseline binge drinking, were evaluated using Generalized Estimating Equations.

resultsData from 255 participants were analyzed: 49.8% were male, median age was 37 years and 28.6% enrolled in Haiti. At study entry, only 2.7% reported illicit substance use, but 22.3% reported binge drinking at least once in the 30 days prior to enrollment. Adherence was higher on weekdays than weekends (median percent doses taken: 96.0% vs 94.4%; 93.7% vs 91.7%; 92.6% vs 89.7% and 93.7% vs 89.7% in quarters 1-4 respectively, all p<0.001). Binge drinking at baseline and time on study were both associated with greater differences between weekday and weekend adherence.

conclusionsAdherence was worse on weekends compared to weekdays: difference was small at treatment initiation, increased over time and was associated with binge drinking. Screening and new interventions to address binge drinking, a potentially modifiable behavior, may improve adherence in HIV-infected individuals in LMIC.

Indexed as

AdultAnti-Retroviral AgentsBinge DrinkingFemaleHIV InfectionsHumansIncomeMaleMedication AdherenceMiddle AgedRandomized Controlled Trials as TopicTime FactorsYoung AdultAnti-Retroviral AgentsAdherenceAlcoholBinge drinkingHIV/AIDSLow and middle income countriesMicroelectronic monitors

Identifiers

PMID26774947
PMCPMC4860880
OpenAlexW2203399818

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.